Topic · page 25 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 961–1,000 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

Clin Exp Rheumatol5 Dec 2024
Lupus or not? Idiopathic full house glomerulonephritis: a rare nephropathy with unexpectedly severe outcome
Cohort study
Semin Arthritis Rheum4 Dec 2024
Damage Index for Antiphospholipid Syndrome (DIAPS): An Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) “Damage” working group report on strengths and limitations
Cross-sectional study
Lupus4 Dec 2024
Identification of IFITM3 as a diagnostic biomarker of systemic lupus erythematosus and its association with disease activity based on multi-omics and experimental verification
Diagnostic or prognostic study
Rheumatology (Oxford)4 Dec 2024
Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort study
Cohort study
Clin Exp Rheumatol2 Dec 2024
A novel nomogram based on the identification of sTREM2 as a biomarker to predict developing neuropsychiatric systemic lupus erythematosus in lupus patients
Diagnostic or prognostic study
Rheumatology (Oxford)2 Dec 2024
Efficacy and safety of guselkumab in patients with active lupus nephritis: results from a phase 2, randomized, placebo-controlled study
Randomized controlled trial
J Rheumatol1 Dec 2024
Epidemiology of Isolated Cutaneous Lupus Erythematosus in the Multiethnic Population of Reunion Island: A Retrospective Multicenter Study
Cohort study
Semin Arthritis Rheum30 Nov 2024
Peripartum maternal outcomes in individuals with systemic lupus erythematosus in a real-world electronic health record cohort
Cohort study
Joint Bone Spine30 Nov 2024
Economic burden of systemic lupus erythematosus and lupus nephritis in France: a nationwide population-based study using the French medico-administrative (SNDS) claims database
Cohort study
Lupus Sci Med28 Nov 2024
Interferon-α as a biomarker to predict renal outcomes in lupus nephritis
Cohort study
Lupus Sci Med27 Nov 2024
Renal response status to predict long-term renal survival in patients with lupus nephritis: results from the Toronto Lupus Cohort
Cohort study
Lupus25 Nov 2024
The problem of pain in systemic lupus erythematosus: A comprehensive analysis of pain distribution using the CHOIR body map and PROMIS measures
Cohort study
Lupus Sci Med24 Nov 2024
Altered structural and functional homotopic connectivity associated with cognitive changes in SLE
Cross-sectional study
Lancet Rheumatol22 Nov 2024
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial
Randomized controlled trial
Lupus Sci Med21 Nov 2024
Evaluation and randomised controlled trial of home urinalysis testing in patients with SLE at elevated risk for developing lupus nephritis: a study protocol
Trial design
Lupus20 Nov 2024
SLE inflammatory musculoskeletal abnormalities, confirmed by MRI, show a specific profile with a worse health-related quality of life
Cross-sectional study
Lupus Sci Med20 Nov 2024
Development of a predictive model for systemic lupus erythematosus incidence risk based on environmental exposure factors
Case-control study
Lupus Sci Med20 Nov 2024
Role of intravenous immunoglobulins in the management of systemic lupus erythematosus: a single-centre experience
Cohort study
RMD Open20 Nov 2024
Utility of the 2019 EULAR/ACR SLE classification criteria for predicting mortality and hospitalisation: development and cross-validation of ominosity score
Cohort study
Arthritis Res Ther19 Nov 2024
Semaphorin 5A promotes Th17 differentiation via PI3K-Akt-mTOR in systemic lupus erythematosus
Mechanistic study
Clin Exp Rheumatol19 Nov 2024
Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohort
Cohort study
Lupus18 Nov 2024
Understanding patient perspectives on health-related searches on the internet: Insights from an online survey of Korean patients with systemic lupus erythematosus
Cross-sectional study
Lupus18 Nov 2024
Current smoking is related to severe damage in systemic lupus erythematosus patients
Cross-sectional study
Rheumatology (Oxford)18 Nov 2024
Association between antiphospholipid antibodies and diffuse alveolar haemorrhage risk in systemic lupus erythematosus: a systematic review and meta-analysis
Meta-analysis
Lupus15 Nov 2024
Reversibility of pulmonary hypertension in systemic lupus erythematosus after induction immunosuppressive therapy: An inflammatory manifestation?
Cohort study
Lupus14 Nov 2024
Real world application of the 2023 ACR/EULAR antiphospholipid antibody syndrome classification criteria in a pharmacist directed anticoagulation clinic
Cohort study
Arthritis Care Res (Hoboken)14 Nov 2024
Clinical Presentation, Care Pathways, and Delays in Access to Specialized Care in Patients With Systemic Lupus Erythematosus: A Study From Lupus Midwest Network (LUMEN)
Cohort study
Arthritis Rheumatol14 Nov 2024
Genetic Analysis of Asymptomatic Antinuclear Antibody Production
Meta-analysis
Arthritis Res Ther12 Nov 2024
Clinical practice pattern of Pneumocystis pneumonia prophylaxis in systemic lupus erythematosus: a cross-sectional study from lupus registry of nationwide institutions (LUNA)
Cross-sectional study
Clin Exp Rheumatol12 Nov 2024
Expression and significance of NF-κB and HSP90 in renal puncture tissues and peripheral blood mononuclear cells of patients with lupus nephritis
Mechanistic study
Lupus11 Nov 2024
Fibromyalgia, mood disorders and chronic damage are the main determinants of worse quality of life in systemic lupus erythematosus patients: Results from a cross-sectional analysis
Cross-sectional study
Arthritis Res Ther11 Nov 2024
Association between discontinuity of care and patient trust in the usual rheumatologist among patients with systemic lupus erythematosus: a cross-sectional study
Cross-sectional study
Arthritis Rheumatol11 Nov 2024
Urinary Biomarkers Associated With Pathogenic Pathways Reflecting Histologic Findings in Lupus Nephritis
Mechanistic study
Arthritis Care Res (Hoboken)10 Nov 2024
Limitations in Activities of Daily Living Among Individuals With Systemic Lupus Erythematosus
Cross-sectional study
Lupus Sci Med9 Nov 2024
Comparison of a voclosporin-based triple immunosuppressive therapy to high-dose glucocorticoid-based immunosuppressive therapy: a propensity analysis of the AURA-LV and AURORA 1 studies and ALMS
Secondary analysis
Arthritis Res Ther7 Nov 2024
Outgrowth of Escherichia is susceptible to aggravation of systemic lupus erythematosus
Case-control study
Lupus7 Nov 2024
Health seeking behaviour and diagnostic delays in SLE: A multi-ethnic Malaysian cohort study
Cross-sectional study
Lupus Sci Med7 Nov 2024
Using photovoice to investigate patient experiences of lupus nephritis in Canada
Research article
Rheumatology (Oxford)4 Nov 2024
QRISK3 and SCORE2 are equally reliable predictors of carotid plaques in patients with systemic lupus erythematosus
Cross-sectional study
J Rheumatol1 Nov 2024
Incidence ofPneumocystis jiroveciiPneumonia and Prophylaxis-Associated Adverse Events Among Patients With Systemic Lupus Erythematosus
Cohort study

All 1,848 Briefs in ExploreShowing Briefs 961–1,000 of 1,848, newest first